For most patients “chemotherapy” brings to mind one picture, a drip and nausea, and there the knowledge ends. Yet understanding how a cycle works is what lets a person plan the trip, their work and the family’s presence.
This page covers chemotherapy for lymphoma in Germany: how the regimen is chosen, what one cycle looks like, how side effects are handled and how it becomes clear that treatment works. For the disease as a whole, see lymphoma treatment in Germany.
How the regimen is chosen
The regimen follows not the name of the disease but the subtype, stage, age and the state of the heart, kidneys and liver. So two patients “with lymphoma” get different treatment, and comparing prescriptions with someone else’s makes no sense.
In most B-cell lymphomas an antibody against CD20, a marker on B lymphocytes, is added to the cytotoxic drugs: the R in R-CHOP stands for such an antibody, rituximab. So it is a combination, not pure chemotherapy: ask the doctor about the whole regimen. Hodgkin lymphoma has its own combinations, such as ABVD or BrECADD by stage; non-Hodgkin lymphomas have theirs, chosen by subtype, as the page on non-Hodgkin lymphoma explains.
The number of cycles is named in advance because lymphomas are treated with a fixed-length course, not “until it helps”. It may change after the interim scan, but the doctor names the starting plan at the first meeting; ask for it in writing.
What one cycle looks like
A cycle is an infusion and a pause. At the start almost every patient gets a port: a small reservoir under the skin below the collarbone with a catheter into a vein. It is fitted under local anaesthesia and spares repeated attempts to find a vein in the arm. Drugs and blood samples go through it, and it is removed when treatment ends.
Most cycles in Germany are given in a day unit: the patient arrives in the morning, has the infusions and leaves. Admission is needed for multi-day infusions or when the patient’s condition requires it. Between cycles the bone marrow recovers, and this alternation of infusion and pause makes up the length of treatment.
For a travelling patient, treatment means repeated visits over months, so ask early how many cycles can realistically be given in Germany and how the rest can pass to the oncologist at home, with a written regimen, drug names and a monitoring plan. For the method as a whole, see chemotherapy in Germany.
Side effects and supportive treatment
Nausea is now prevented rather than treated: anti-emetics are given before the cytotoxic drugs, which has greatly changed tolerability compared with what older relatives remember. Still, no one can promise an absence of side effects. The side effects of chemotherapy are described in detail by the Krebsinformationsdienst of the German Cancer Research Center (in German).
The real danger is not nausea but the fall in white blood cells a few days after the infusion: any fever then means seeing a doctor at once, not waiting until morning. In Germany patients get a written note with a phone number and the temperature at which to come to hospital, and it must be translated.
A conversation often skipped in the rush is fertility preservation: freezing sperm or tissue is discussed before treatment, not after, and young patients should raise it themselves if the doctor does not. Mouth care, vaccination to the hospital’s plan and heart monitoring with drugs that can harm the heart, such as doxorubicin, belong here too: an ECG and an echocardiogram, a heart ultrasound, come first.
How it becomes clear that the treatment is working
The response is judged not by how the patient feels or by a blood count but by PET-CT. An interim scan mid-course shows whether the tumour is responding and can change the number of remaining cycles: in Hodgkin lymphoma it decides how many are needed in total. The final scan sums up the course. The page on PET-CT in Germany describes the examination itself.
If the response is insufficient or the disease returns, a second line is discussed, and for some patients high-dose chemotherapy with a return of their own stem cells, a much heavier stage with a long hospital stay. Recovery after treatment takes time, and Germany has dedicated oncological rehabilitation programmes for it: see the page on rehabilitation for cancer patients.
Frequently asked questions
How long does chemotherapy for lymphoma take?
Usually several months; the exact time depends on the regimen and the number of cycles, which the doctor names in advance. Add time for tests before the start and for the final PET-CT, done several weeks after the last infusion. So plan the whole course, not single trips.
Does chemotherapy for lymphoma make your hair fall out?
Often, yes: many lymphoma regimens include drugs that cause hair loss, such as cyclophosphamide. It usually begins a few weeks into treatment and happens gradually. No medicine prevents it. After the course, hair usually grows back within weeks or months.
Can I fly home between cycles?
Sometimes, but the treating haematologist decides. Each cycle needs a blood test and examination first, and while white cells are low, a fever means going straight to a doctor who knows your regimen. So patients either stay nearby for the whole course or agree in advance which cycles will be given at home under a written plan.
How AlenMed arranges chemotherapy for lymphoma
AlenMed starts with the documents: the pathology report, slides and blocks, image files, blood results, the echocardiogram and discharge letters go to a haematology department, whose doctor says which regimen is planned, how many cycles and what must be repeated on site. Then come a written estimate, a visa invitation, an interpreter at appointments and a place for a companion; the page on the cost of chemotherapy for lymphoma breaks the sum down. AlenMed’s partners include the Rotkreuzklinikum in Munich, where Prof. Marcus Hentrich heads the department of haematology and oncology and the Centre for Haematological Neoplasms, and München Klinik Bogenhausen, whose department of haematology, oncology and stem cell transplantation is led by Prof. Tobias Herold.
Plan for housing near the hospital through the cycle and pause, enough of your usual medicines, a return date that a blood count may shift, and a translated final discharge letter with the regimen for your doctor at home.
This material is for information only and is not an offer. The regimen and the number of cycles are decided by a doctor in person.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.


